USFDA warning on Baidyanath supplements

The US Food and Drug Administration has warned consumers against the use of certain dietary supplements manufactured by Shree Baidyanath Ayurved Bhawan, being sold in the US, as they contain high levels of lead andor mercury Stock Market Trading Tips

Testing by the New York Department of Health and USFDA has found that these products contain high levels of lead and or mercury, which can cause serious health problems, says a communication posted on the regulator's website. A company official told TOI that all its products were approved by the Indian FDA. 

The USFDA has recommended that consumers avoid the following products: Baidyanath Agnitundi Bati, Baidyanath Arogyavardhini Bati, Baidyanath Brahmi Bati, Baidyanath Chitrakadi Bati, Baidyanath Gaisantak Bati, Baidyanath Marichyadi Bati, Baidyanath Rajahpravartini Bati, Baidyanath Saptamrit Lauh, Baidyanath Sarivadi Bati and Shankh Bati Financial Asttrology Trading Tips 

"All Baidyanath products are approved by Indian FDA and conform to standards set by Indian pharmacopeia.The products contain ayurvedic metallic preparations duly manufactured in accordance with the procedures laid out in the ayurvedic texts by virtue of which they are rendered purified, non-toxic and endowed with medicinal properties. In this context, the Ayush ministry has clarified the matter to US FDA," a company official told TOI Commodity Market Astrology Tips